Developmental origins of cardiovascular disease, type 2 diabetes and obesity in humans

被引:0
|
作者
Fall, CHD [1 ]
机构
[1] Univ Southampton, MRC Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England
来源
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Fecal growth restriction and low weight gain in infancy are associated with an increased risk of adult cardiovascular disease, type 2 diabetes and the Metabolic Syndrome. The fetal origins of adult disease hypothesis proposes that these associations reflect permanent changes in metabolism, body composition and tissue structure caused by undernutrition during critical periods of early development. An alternative hypothesis is that both small size at birth and later disease have a common genetic aetiology. These two hypotheses are not mutually exclusive. In addition to low birthweight, fetal 'overnutrition' caused by maternal obesity and gestational diabetes leads to an increased risk of later obesity and type 2 diabetes. There is consistent evidence that accelerated BMI gain during childhood, and adult obesity, are additional risk factors for cardiovascular disease and diabetes. These effects are exaggerated in people of low birthweight. Poor fetal and infant growth combined with recent increases in childhood adiposity may underlie the high rates of disease in developing countries undergoing nutritional transition. Sub-optimal maternal nutritional status is a major cause of low birthweight globally but its impact on fetal growth in 'well-nourished' western populations has been inadequately studied. In experimental animals hypertension and insulin resistance can be programmed in the offspring by restricting maternal diet in pregnancy but there are currently insufficient data to determine whether maternal nutritional status and diet programme cardiovascular disease risk in humans.
引用
收藏
页码:8 / 28
页数:21
相关论文
共 50 条
  • [41] Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk
    Malik, Vasanti S.
    Popkin, Barry M.
    Bray, George A.
    Despres, Jean-Pierre
    Hu, Frank B.
    [J]. CIRCULATION, 2010, 121 (11) : 1356 - 1364
  • [42] Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer
    Janssen, Joseph A. M. J. L.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [43] Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease
    Thomas, G.
    Khunti, K.
    Curcin, V.
    Molokhia, M.
    Millett, C.
    Majeed, A.
    Paul, S.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (04): : 317 - 325
  • [44] The influence of carbohydrate quality on cardiovascular disease, the metabolic syndrome, type 2 diabetes, and obesity - an overview
    Slyper, Arnold H.
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2013, 26 (7-8): : 617 - 629
  • [45] Sex differences in the developmental origins of cardiometabolic disease following exposure to maternal obesity and gestational diabetes
    Talbot, Charlotte Pauline Joelle
    Dolinsky, Vernon Wayne
    [J]. APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2019, 44 (07) : 687 - 695
  • [46] Developmental Origins of Common Disease: Epigenetic Contributions to Obesity
    Kappil, Maya
    Wright, Robert O.
    Sanders, Alison P.
    [J]. ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 17, 2016, 17 : 177 - 192
  • [47] Prevention of Diabetes and Cardiovascular Disease in Obesity
    La Sala, Lucia
    Pontiroli, Antonio E.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 17
  • [48] Pancreatic duct replication is increased with obesity and type 2 diabetes in humans
    A. E. Butler
    R. Galasso
    A. Matveyenko
    R. A. Rizza
    S. Dry
    P. C. Butler
    [J]. Diabetologia, 2010, 53 : 21 - 26
  • [49] Pancreatic duct replication is increased with obesity and type 2 diabetes in humans
    Butler, A. E.
    Galasso, R.
    Matveyenko, A.
    Rizza, R. A.
    Dry, S.
    Butler, P. C.
    [J]. DIABETOLOGIA, 2010, 53 (01) : 21 - 26
  • [50] Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
    Thwe Htay
    Kyaw Soe
    Arianna Lopez-Perez
    Amy HoangAnh Doan
    Michael A. Romagosa
    KoKo Aung
    [J]. Current Cardiology Reports, 2019, 21